methotrexate
To evaluate the efficacy and safety of additive triple disease modifying       anti-rheumatic drug (DMARD) combination therapy of a low dose of sulfhydryl       compounds inverted question markD-penicillamine, bucillamine or tiopronin       inverted question mark, sulfasalazine (SSZ) and methotrexate (MTX) as a treatment       for rheumatoid arthritis (RA) patients, we studied a total of 33 Japanese RA       patients (6 males, 27 females).
To evaluate the efficacy and safety of additive triple disease modifying       anti-rheumatic drug (DMARD) combination therapy of a low dose of sulfhydryl       compounds inverted question markD-penicillamine, bucillamine or tiopronin       inverted question mark, sulfasalazine (SSZ) and  @SUBJECT$  (MTX) as a  @PREDICAT$        for  @OBJECT$  (RA) patients, we studied a total of 33 Japanese RA       patients (6 males, 27 females).